She is committed to leveraging her C-suite role to continue to make strategic contributions, create value, and drive company development to bolster AliveDx's standing in the health care arena.
BELMONT, MA, March 19, 2024 /24-7PressRelease/ -- Nadia F. Altomare, MBA, has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Ms. Altomare has carved out a distinguished career in the health care sector, bringing over two decades of experience to her current role as chief commercial officer at AliveDx, formerly Quotient Limited, a commercial-stage diagnostics company with over 30 years of in-vitro diagnostics experience. She joined the Switzerland-based enterprise in late 2022 and is responsible for the company's commercialization, strategy and execution.
Along with her current role at AliveDx, Ms. Altomare has maintained a position on Savran Technologies Inc.'s board of directors since 2019. Building toward her present success, she attended Stony Brook University, where she obtained a bachelor's degree in international business in 1991, and went on to graduate from Northeastern University in 1995 with a Master of Business Administration. Coupled with her degrees, the foundational experience she gained working in operations from 1991 to 1998 propelled her to ascend the corporate ladder in the health care sector.
Subsequently, Ms. Altomare joined PerkinElmer, where she made significant contributions over a span of nearly 10 years to ViaCord and ViaCell. After starting as a sales manager for ViaCord, she became a senior manager of sales and services, followed by director of sales and service, and finally senior director of sales, services, and commercial operations. For her impactful contributions to organizational enhancement, she was rewarded with stock option contributions along with the 2005 Tree of Life Award, recognizing her assistance in taking ViaCell public. She has proven to be instrumental in commercialization efforts, customer engagement, and profitability enhancement. Moreover, her strategic approach has maximized the company's valuation and ensured its sustained success.
As a result of her dedication, impact, and experience, Ms. Altomare stepped into the role of vice president of sales, service, and commercial operations for PerkinElmer's Boston branch in 2008, a role she held for several years, before overseeing the Spokane, Washington, branch as vice present and general manager. Following her time at PerkinElmer, her journey led her to Thermo Fisher Scientific, where she applied her leadership experience as their vice president and general manager from 2012 to 2014, further solidifying her expertise in managing product lines and driving business growth. Demonstrating her versatility and leadership acumen, she joined Abcodia's board of directors as a member and simultaneously served as president before holding the position of chief executive officer for the global business between 2014 and 2017.
Ms. Altomare's time at Abcodia continued when she became a non-executive director and consultant, a position she held until 2018. Concurrently, she served as Sera Prognostics' chief commercial officer from 2017 to 2023, where she played a critical role in the company's commercial trajectory, leading to its public offering. She won the company's IPO Award in 2020. In all she has pursued and achieved within the health care arena, Ms. Altomare attributes her success to an expansive network that has facilitated her progression through various opportunities and learning experiences from industry leaders.
Outside of her professional endeavors, Ms. Altomare is deeply passionate about culture, core values, theater, music, and travel, interests that expand her multi-cultural upbringing and her global perspective. In addition to her personal hobbies, she served on the board of several organizations that focus on aiding different communities, including St. Jude Children's Research, Patient Rights Advocate, the Boston chapter of March of Dimes, and currently serves on the board of Patient Rights Advocate. Furthermore, she extends her resources to global communities and recently donated to earthquake victims and recently aided survivors in Morocco through her generosity.
As she continues on in her career, Ms. Altomare remains committed to leveraging her C-suite role to continue to make strategic contributions, create value, and drive company development to bolster AliveDx's standing in the health care arena. Along with utilizing her keen eye for opportunity, she is poised to engage with the Switzerland chapter of the Healthcare Businesswomen's Association, where she previously collaborated with the organization's global group and served as the Boston chapter president.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #